Net Cash Provided by (Used in) Operating Activities |
-261 |
USD |
-130% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q4 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
14.4M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
868 |
USD |
|
Q4 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.02K |
USD |
-75.4% |
Q2 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
34.9K |
USD |
+18.6% |
Q3 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
34.9K |
USD |
+18.6% |
Q3 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Additional Paid in Capital |
62.7K |
USD |
0% |
Q2 2023 |
Q3 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |